Jardim reviews Reassessing the Nuremberg Military Tribunals: Transitional Justice, Trial Narratives, and Historiography edited by Kim C. Priemel and Alexa Stiller.
In the present work we describe the first occurrence of the genus Orthophytum (Bromeliaceae, Bromelioideae) and of the species Tillandsia paraibensis within the state of Rio Grande do Norte, ...northeastern Brazil. Both taxa were recorded on inselbergs in areas of caatinga. These findings are important, improving the knowledge of the Flora of Rio Grande do Norte and giving a better understand of the biogeography of Brazilian bromeliads.
To correlate physical activity level (PAL), functional capacity and psychological state with quality of life (QoL) in cancer patients undergoing chemotherapy (CT).
Observational cohort study. ...Patients (n=121) with any primary cancer site with indications of chemotherapy with palliative or curative intent were evaluated at three moments: 1) patient admission (week 0), before chemotherapy; 2) week 8; 3) end of CT. Data were collected regarding QoL, PAL, clinical data, functional capacity (short walking distance test, sitting-rising test, isometric manual gripping force), and anxiety and depression tests.
There was significant improvement at the end of CT for: level of physical activity; walk test (> 500 meters); sitting-rising test (> 20x). There was a significant reduction in the prevalence of moderate/severe depression. The prevalence of high QoL showed a significant increase in evaluation 3 (42.4% vs. 40.0% vs. 59.2%, p=0.02). Education up to high school level, low PAL, walking < 300 meters, sitting and rising < 20 times, having depression (moderate to severe) and QoL that was not high at the start of treatment (week 0) all proved to be risk factors for low quality of life at week 16. Conversely, early staging, curative intent chemotherapy and low-grade symptoms were shown to be protective factors.
Performing less than 20 movements in the sitting-rising test and low PAL at the start of chemotherapy represent independent risk factors for low quality of life at the end of chemotherapy.
PDF
